These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33846810)

  • 21. lncRNA prostate cancer-associated transcript 18 upregulates activating transcription factor 7 to prevent metastasis of triple-negative breast cancer via sponging miR-103a-3p.
    Zhang J; Liu D; Deng G; Wang Q; Li L; Zhang J; Wu H
    Bioengineered; 2021 Dec; 12(2):12070-12086. PubMed ID: 34787047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
    Xiong L; Tang Y; Tang J; Liu Z; Wang X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
    [No Abstract]   [Full Text] [Related]  

  • 23. LncRNA HEIH regulates cell proliferation and apoptosis through miR-4458/SOCS1 axis in triple-negative breast cancer.
    Li P; Zhou B; Lv Y; Qian Q
    Hum Cell; 2019 Oct; 32(4):522-528. PubMed ID: 31456112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA FEZF1-AS1 Modulates Cancer Stem Cell Properties of Human Gastric Cancer Through miR-363-3p/HMGA2.
    Hui Y; Yang Y; Li D; Wang J; Di M; Zhang S; Wang S
    Cell Transplant; 2020; 29():963689720925059. PubMed ID: 32638620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression.
    Fan H; Yuan J; Li X; Ma Y; Wang X; Xu B; Li X
    Biomed Pharmacother; 2020 May; 125():109987. PubMed ID: 32058222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non‑coding RNA TTN‑AS1 regulates the proliferation, invasion and migration of triple‑negative breast cancer by targeting miR‑211‑5p.
    Sun E; Liu X; Lu C; Liu K
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LINC00473 promotes hepatocellular carcinoma progression via acting as a ceRNA for microRNA-195 and increasing HMGA2 expression.
    Mo J; Li B; Zhou Y; Xu Y; Jiang H; Cheng X; Wu X; Zhang Y
    Biomed Pharmacother; 2019 Dec; 120():109403. PubMed ID: 31562977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TCF3-activated FAM201A enhances cell proliferation and invasion via miR-186-5p/TNKS1BP1 axis in triple-negative breast cancer.
    Jia H; Wu D; Zhang Z; Li S
    Bioorg Chem; 2020 Nov; 104():104301. PubMed ID: 33011533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
    Han C; Li X; Fan Q; Liu G; Yin J
    Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
    Han C; Fu Y; Zeng N; Yin J; Li Q
    Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
    Luo N; Zhang K; Li X; Hu Y
    J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.
    Wang X; Chen T; Zhang Y; Zhang N; Li C; Li Y; Liu Y; Zhang H; Zhao W; Chen B; Wang L; Yang Q
    J Cell Physiol; 2019 Aug; 234(8):13303-13317. PubMed ID: 30618083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6.
    Eades G; Wolfson B; Zhang Y; Li Q; Yao Y; Zhou Q
    Mol Cancer Res; 2015 Feb; 13(2):330-8. PubMed ID: 25253741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer.
    Hua K; Deng X; Hu J; Ji C; Yu Y; Li J; Wang X; Fang L
    J Exp Clin Cancer Res; 2020 Apr; 39(1):58. PubMed ID: 32248842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other.
    Liu AN; Qu HJ; Gong WJ; Xiang JY; Yang MM; Zhang W
    J Cell Biochem; 2019 Sep; 120(9):14860-14866. PubMed ID: 31033015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of long non-coding RNA HOST2 inhibits the proliferation of triple negative breast cancer via regulation of the let-7b/CDK6 axis.
    Zhang Y; Zhang H; Kang H; Huo W; Zhou Y; Zhang Y
    Int J Mol Med; 2019 Feb; 43(2):1049-1057. PubMed ID: 30483747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA SLC16A1-AS1 regulates the miR-182/PDCD4 axis and inhibits the triple-negative breast cancer cell cycle.
    Jiang B; Liu Q; Gai J; Guan J; Li Q
    Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):534-540. PubMed ID: 35316129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA (lncRNA) metallothionein 1 J, pseudogene (MT1JP) is downregulated in triple-negative breast cancer and upregulates microRNA-138 (miR-138) to downregulate hypoxia-inducible factor-1α (HIF-1α).
    Wang G; Dong Y; Liu H; Ji N; Cao J; Liu A; Tang X; Ren Y
    Bioengineered; 2022 May; 13(5):13718-13727. PubMed ID: 35703312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p.
    Xing L; Tang X; Wu K; Huang X; Yi Y; Huan J
    Aging (Albany NY); 2020 Dec; 13(1):424-436. PubMed ID: 33290256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SChLAP1 promotes prostate cancer development through interacting with EZH2 to mediate promoter methylation modification of multiple miRNAs of chromosome 5 with a DNMT3a-feedback loop.
    Huang K; Tang Y
    Cell Death Dis; 2021 Feb; 12(2):188. PubMed ID: 33589600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.